MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,079,000 | +57.7% | 58,662 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $1,952,000 | +22.3% | 58,662 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $1,596,000 | +38.3% | 58,662 | +0.3% | 0.01% | +66.7% |
| Q4 2019 | $1,154,000 | +52.2% | 58,482 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $758,000 | +4.1% | 58,482 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $728,000 | -7.4% | 58,482 | +8.2% | 0.00% | 0.0% |
| Q1 2019 | $786,000 | +31.7% | 54,062 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $597,000 | -58.0% | 54,062 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $1,422,000 | +28.6% | 54,062 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $1,106,000 | +13.9% | 54,062 | +1.0% | 0.00% | 0.0% |
| Q1 2018 | $971,000 | +30.2% | 53,502 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $746,000 | -24.6% | 53,502 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $990,000 | +9.5% | 53,502 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $904,000 | +26.6% | 53,502 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $714,000 | -11.3% | 53,502 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $805,000 | +28.8% | 53,502 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $625,000 | +8.1% | 53,502 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $578,000 | +17.0% | 53,502 | +0.0% | 0.00% | 0.0% |
| Q1 2016 | $494,000 | -37.8% | 53,490 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $794,000 | -9.6% | 53,490 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $878,000 | -28.0% | 53,490 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $1,220,000 | +52.5% | 53,490 | +1.6% | 0.00% | +33.3% |
| Q1 2015 | $800,000 | +22.7% | 52,649 | -2.7% | 0.00% | +50.0% |
| Q4 2014 | $652,000 | +6.2% | 54,129 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $614,000 | -6.1% | 54,129 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $654,000 | +5.1% | 54,129 | +1.4% | 0.00% | 0.0% |
| Q1 2014 | $622,000 | -34.1% | 53,382 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $944,000 | +22.9% | 53,382 | 0.0% | 0.00% | +50.0% |
| Q3 2013 | $768,000 | -4.5% | 53,382 | 0.0% | 0.00% | -33.3% |
| Q2 2013 | $804,000 | – | 53,382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
| Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
| Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
| Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
| Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
| Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
| Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
| Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
| Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
| Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |